Cite
HARVARD Citation
Jädersten, M. et al. (2022). Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial. Journal of internal medicine. pp. 925-940. [Online].